Pay in 4 interest-free payments of $6.21 Learn more
Ships within 48 hours · Estimated delivery Aug 15 - Aug 20
The launch of our GLP-1 weight management solution is the latest example of our commitment to helping our employer clients with improved utilization of these drugs through better management of medication costs while ensuring members receive high-value, appropriate care, said Dayne Williams, CEO of Quantum Health
doi: 10.1371/journal.pone.0095319 282 SmithP
Somapacitan (Sogroya), a long-acting GH analog approved in 2020, requires only once-weekly injection and demonstrated non-inferiority to daily somatropin in the REAL 1 trial (N=136) [19]
A provider familiar with both medications and midlife hormonal health is the best resource
Enhertu (trastuzumab deruxtecan) | $139,800 avg
US$ 22.78
US$ 22.67
US$ 25.61
US$ 28.02
